Dexmedetomidine

adrenoceptor alpha 2A ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33915198 The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study. 2022 Mar-Apr 5
2 35191924 Effect of Sublingual Dexmedetomidine vs Placebo on Acute Agitation Associated With Bipolar Disorder: A Randomized Clinical Trial. 2022 Feb 22 1
3 35245122 Structural insights into ligand recognition, activation, and signaling of the α2A adrenergic receptor. 2022 Mar 4 1
4 35429176 A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients. 2022 Jun 3
5 34868950 Effects of Perioperative Dexmedetomidine on Immunomodulation in Uterine Cancer Surgery: A Randomized, Controlled Trial. 2021 1
6 32256718 Effect of ADRA2A gene polymorphisms on the anesthetic and analgesic effects of dexmedetomidine in Chinese Han women with cesarean section. 2020 Apr 3
7 31168973 Relationship between genetic variation in the α2A-adrenergic receptor and the cardiovascular effects of dexmedetomidine in the Chinese Han population. 2019 Jul 5
8 29897736 Dexmedetomidine, an Alpha 2a Adrenergic Receptor Agonist, Mitigates Experimental Autoimmune Encephalomyelitis by Desensitization of CXCR7 in Microglia. 2018 Jul 17 3
9 23873118 Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose. 2013 Sep 2
10 21104443 The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery. 2011 Jun 5
11 21325151 Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine. 2011 Apr 3